Skip to main content
. 2022 Jan 13;107(9):2108–2120. doi: 10.3324/haematol.2021.279012

Figure 1.

Figure 1.

Progression-free survival per investigator assessment in the intention-to-treat population. CI: confidence interval; mo: months; NE, not estimable; PFS, progression-free survival.